EHC vs THC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
THC Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenet Healthcare Corporation New (THC) driven by superior Valuation, Growth & Margin, Options & Structure while EHC counters with relative strength in Momentum & Technical. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus THC at 13.0x Forward P/E and 19.1% operating margin (+6.5% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against THC sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EHC Revenue | THC Revenue | EHC Op. Margin | THC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $4.28B | $18.3B | 13.0% | 8.9% | EHC |
| FY2019 | $4.61B | $18.5B | 13.3% | 8.3% | EHC |
| FY2020 | $3.57B | $17.6B | 15.8% | 11.3% | EHC |
| FY2021 | $4.01B | $19.5B | 13.9% | 14.7% | THC |
| FY2022 | $4.35B | $19.2B | 12.4% | 12.2% | EHC |
| FY2023 | $4.80B | $20.6B | 7.3% | 12.2% | THC |
| FY2024 | $5.37B | $20.7B | 8.5% | 28.8% | THC |
| FY2025 | $5.94B | $21.3B | 9.5% | 16.5% | THC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EHC | THC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.0B | $21.0B | Larger Scale | THC |
| Trailing P/E Ratio Valuation | 21.2x | 7.7x | Lower Multiple | THC |
| Forward P/E Ratio Valuation | 19.4x | 13.0x | Lower Multiple | THC |
| Revenue Growth (YoY) Growth | +8.9% | +6.5% | Higher Growth | EHC |
| Operating Margin (TTM) Profitability | 18.4% | 19.1% | Higher Margin | THC |
| Net Profit Margin Profitability | 10.2% | 13.1% | Higher Margin | THC |
| Return on Equity (ROE) Capital Efficiency | 25.1% | 41.7% | Higher ROE | THC |
| 52-Week Range Position Momentum | 80% ($93โ$144) | 73% ($158โ$301) | Stronger Trend | EHC |
| Beta / 30D Volatility Risk Regime | -0.10ฮฒ ยท 40% Vol | 0.53ฮฒ ยท 44% Vol | Lower Realized Risk | EHC |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 50.3 / 100 (HOLD) | Higher Composite | EHC |